RevBio® Receives Approval from FDA to Start a Dental Clinical Trial for its Regenerative Bone Glue

LOWELL, Mass.–(BUSINESS WIRE)– #Biomimetic–RevBio, Inc., announced that it has received approval from the U.S. Food and Drug Administration to start a pilot clinical trial to examine the safety and efficacy of TETRANITE®, the company’s regenerative bone adhesive, to perform dental ridge augmentation procedures without the need for ancillary containment devices like membranes or meshes or fixation aids like tacks and screws. “The ability for the product to adhere to the surrounding bony walls of a site tha